Can the <scp>THC</scp> concentration predict the number of patients with cannabis‐related diagnoses?
Compared to low-potency products, using high-potency products may pose additional health risks, which may be particularly pronounced in men. Acknowledging the limitations of the ecological study design and uncertainties inherent to the analysed data, further investigations on the sex-specific impact of THC exposure are required. Limiting the THC concentration in cannabis products and closely monitoring THC consumption in the population appears necessary.
Authors
- Benjamin Jonas (ORCID: https://orcid.org/0000-0002-9146-1501)
- Jakob Manthey (ORCID: https://orcid.org/0000-0003-1231-3760)
- Larissa Schwarzkopf (ORCID: https://orcid.org/0000-0002-9402-7700)
- Moritz Rosenkranz (ORCID: https://orcid.org/0000-0002-0851-6330)
Institutions
- Universität Hamburg (DE)
- Zimmer Biomet (Germany) (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Zentralinstitut für die Kassenärztliche Versorgung in der Bundesrepublik Deutschland (DE)
- IFT Institut für Therapieforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1111/dar.13923
- Citations
- 3
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.34